Edwards Lifesciences Corporation (EW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Edwards Lifesciences Corporation (EW) is up 2.0% since the beginning of the year. At $87 per share, EW is trading just below its 52-week high of $90. Investors who bought $1,000 worth of EW shares 5 years ago would now be looking at an investment worth $838.

Edwards Lifesciences Corporation (EW) has returned 1.99% so far this year and 15.44% over the past 12 months. Over the last ten years, EW has returned 10.51% per year, falling short of the S&P 500 Index benchmark, which averaged 13.71% annually.

Based on dividend-adjusted daily data since Mar 27, 2000, EW's average daily return is +0.09%, while the average monthly return is +1.72%. At this rate, an investment would double in approximately 3.4 years.

Historically, 61% of months were positive and 39% were negative. The best month was May 2000 with a return of +35.4%, while the worst month was Oct 2000 at -38.4%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 4 months.

On a daily basis, EW closed higher 52% of trading days. The best single day was Jul 24, 2002 with a return of +17.9%, while the worst single day was Oct 31, 2000 at -41.4%.

Edwards Lifesciences Corporation has an annualized alpha of 17.70%, beta of 0.71, and R2 of 0.17 versus S&P 500 Index. Calculated based on daily prices since March 27, 2000.

• This stock captured 103.33% of S&P 500 Index gains but only 51.84% of its losses - a favorable profile for investors.
• R2 of 0.17 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

EW ranks 62 for risk / return — better than 62% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Edwards Lifesciences Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Edwards Lifesciences Corporation was 54.32%, occurring on Jul 25, 2024. The portfolio has not yet recovered.

The current Edwards Lifesciences Corporation drawdown is 33.46%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Edwards Lifesciences Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Edwards Lifesciences Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.